Kromek Group plc (KMK.L)
Sedgefield, GB
Kromek Group plc, a UK-based entity established in 2013 with headquarters in Sedgefield, specializes in the design, production, and global distribution of advanced radiation detection components and devices. These technologies provide high-resolution data on material composition and structure, serving critical applications across diverse markets such as medical imaging, the civil nuclear sector, CBRNe security, and safety screening. Its reach extends across the United Kingdom, North America, Asia, Europe, Australasia, and Africa. The company's innovative solutions are employed for various purposes, from identifying cancerous tissues and hazardous substances like explosives, to analyzing radioactive materials. Within the civil nuclear industry, Kromek offers sophisticated gamma and neutron detectors, high-specification, high-resolution devices, essential components, and specialized software designed to address complex nuclear detection challenges. These often utilize cadmium zinc telluride (CZT) or scintillator technologies for the detection of gamma rays, x-rays, and neutrons. For medical imaging, their portfolio includes CZT gamma detectors for SPECT, CZT bone mineral densitometry detectors, and cutting-edge photon-counting spectral CT systems. Kromek also provides CBRNE homeland security products and comprehensive solutions for a wide range of clients, including government agencies, border control, airports, seaports, HazMat teams, ambulance crews, police, and armed forces. This offering features specialized gamma spectroscopy software for in-depth sample analysis. Furthermore, the company supports scientific research and development through its CZT imaging development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array, designed for laboratory and research applications. Kromek distributes its products through a combination of distributors, original equipment manufacturers (OEMs), and direct sales channels.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -9.52% | -20.83% | +46.15% | +6.98% | +57.02% | +80.95% | -26.92% | -68.63% | -83.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Hardware, Equipment & Parts: +10.0%+36.6% ★ Q4'25: +111.6% (vs Q4'23)
-
EPS growth Hardware, Equipment & Parts: +20.2%+205.5% ★ Q4'25: +186.8% (vs Q4'23)
-
FCF margin FCF growth · Hardware, Equipment & Parts: +27.1%+31.2% Q4'25: +8.5% (vs Q4'23)
-
EBIT margin Hardware, Equipment & Parts: +8.7%+17.9% ★ Q4'25: +21.4% (vs Q4'23)
-
ROIC Hardware, Equipment & Parts: +5.7%+6.8% ★ Q4'25: +20.3% (vs Q4'23)
-
Share dilution Hardware, Equipment & Parts: +0.0%+7.9% Q4'25: +15.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Hardware, Equipment & Parts: -0.70×0.66× Q4'25: 0.35× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Apr 2014 actual |
Apr 2015 actual |
Apr 2016 actual |
Apr 2017 actual |
Apr 2018 actual |
Apr 2019 actual |
Apr 2020 actual |
Apr 2021 actual |
Apr 2022 actual |
Apr 2023 actual |
Apr 2024 actual |
Apr 2025 actual |
Apr 2026 1 Rev. Ana. 1 EPS Ana. |
Apr 2027 1 Rev. Ana. 1 EPS Ana. |
Apr 2028 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.97M
est: 5.99M (-0.3%)
|
8.10M
est: 8.10M (+0.0%)
|
8.34M
est: 8.40M (-0.7%)
|
8.97M
est: 8.85M (+1.3%)
|
11.85M
est: 12.11M (-2.2%)
|
14.52M
est: 15.13M (-4.1%)
|
13.12M
est: 14.50M (-9.5%)
|
10.35M
est: 10.00M (+3.5%)
|
12.06M
est: 12.10M (-0.4%)
|
17.31M
est: 17.65M (-1.9%)
|
19.40M
est: 19.40M (+0.0%)
|
26.51M
est: 26.50M (+0.0%)
|
27.19M
27.10M – 27.28M
+2.6% YoY
|
30.42M
30.34M – 30.50M
+11.9% YoY
|
35.00M
34.91M – 35.09M
+15.1% YoY
|
| EBITDA |
-2.47M
est: 49.1K (-5,122.2%)
|
-1.65M
est: -5.21M (+68.4%)
|
-2.52M
est: -1.75M (-43.9%)
|
-1.57M
est: -2.87M (+45.2%)
|
386.0K
est: -2.28M (+117.0%)
|
1.93M
est: -42.3K (+4,668.9%)
|
-14.41M
est: 1.02M (-1,507.6%)
|
-1.74M
est: -23.29M (+92.5%)
|
-1.23M
est: -28.77M (+95.7%)
|
-1.25M
est: -35.60M (+96.5%)
|
2.93M
est: 159.2K (+1,739.2%)
|
6.16M
est: 217.5K (+2,731.3%)
|
223.1K
222.4K – 223.9K
+2.6% YoY
|
249.6K
249.0K – 250.3K
+11.9% YoY
|
287.2K
286.5K – 288.0K
+15.1% YoY
|
| EBIT |
-3.77M
est: -1.52M (-147.3%)
|
-3.03M
est: -5.60M (+45.8%)
|
-4.06M
est: -2.95M (-37.7%)
|
-3.75M
est: -4.33M (+13.3%)
|
-2.31M
est: -5.16M (+55.3%)
|
-751.0K
est: -2.83M (+73.5%)
|
-17.74M
est: -882.7K (-1,909.8%)
|
-5.78M
est: -2.54M (-127.5%)
|
-5.55M
est: -32.91M (+83.1%)
|
-6.05M
est: -40.73M (+85.2%)
|
-1.58M
est: -4.93M (+67.9%)
|
4.74M
est: -6.74M (+170.3%)
|
-6.91M
-6.93M – -6.89M
-2.6% YoY
|
-7.73M
-7.75M – -7.71M
-11.9% YoY
|
-8.90M
-8.92M – -8.87M
-15.1% YoY
|
| Net Income |
-3.19M
est: -25.18M (+87.3%)
|
-2.15M
est: -4.72M (+54.6%)
|
-2.15M
est: -2.06M (-4.2%)
|
-3.08M
est: -2.29M (-34.6%)
|
-1.10M
est: -4.24M (+74.0%)
|
-633.0K
est: -1.34M (+52.6%)
|
-16.54M
est: -275.7K (-5,898.6%)
|
-5.35M
est: -24.75M (+78.4%)
|
-4.92M
est: -30.58M (+83.9%)
|
-6.10M
est: -6.10M (+0.0%)
|
-3.29M
est: -3.29M (+0.0%)
|
3.75M
est: 4.75M (-21.0%)
|
2.42M
2.41M – 2.42M
-49.2% YoY
|
1.26M
1.25M – 1.26M
-47.9% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
8.37M
est: 5.15M (+62.6%)
|
8.75M
est: 6.96M (+25.6%)
|
8.51M
est: 7.22M (+17.8%)
|
8.86M
est: 8.18M (+8.2%)
|
9.03M
est: 10.23M (-11.8%)
|
9.22M
est: 8.61M (+7.0%)
|
10.95M
est: 7.22M (+51.6%)
|
11.22M
est: 8.60M (+30.5%)
|
12.76M
est: 10.40M (+22.6%)
|
15.18M
est: 15.17M (+0.0%)
|
12.60M
est: 16.68M (-24.4%)
|
16.69M
est: 22.78M (-26.7%)
|
23.38M
23.30M – 23.46M
+2.6% YoY
|
26.15M
26.08M – 26.22M
+11.9% YoY
|
30.09M
30.01M – 30.17M
+15.1% YoY
|
| EPS |
-0.05
est: -0.04 (-21.5%)
|
-0.02
est: -0.03 (+29.8%)
|
-0.02
est: -0.03 (+43.6%)
|
-0.02
est: -0.02 (+13.6%)
|
0.00
est: -0.01 (+51.9%)
|
0.00
est: 0.00 (+14.3%)
|
-0.05
est: -0.01 (-317.4%)
|
-0.01
est: -0.02 (+9.6%)
|
-0.01
est: -0.01 (-8.6%)
|
-0.01
est: -0.01 (+2.8%)
|
-0.01
est: -0.01 (-10.0%)
|
0.01
est: 0.01 (-20.3%)
|
0.00
0.00 – 0.00
-49.2% YoY
|
0.00
0.00 – 0.00
-47.9% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-28 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-27 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-05 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-01 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 1/5 | 4/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 1/5 | 4/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Arnab Basu | Chief Executive Officer & Executive Director | 566.0K | — |
| Albertus Beumer | Chief Commercial Officer, President of Advanced Imaging Division & Executive Director | 537.0K | male |
| Claire Burgess | Chief Financial Officer, Company Secretary & Director | 232.0K | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KMK.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
